Buddhachinaraj Phitsanulok Hospital is the main hospital of Phitsanulok Province, Thailand, and is classified under the Ministry of Public Health as a regional hospital. It has a CPIRD Medical Education Center which trains doctors of the Faculty of Medicine, Naresuan University.

There are 922 beds in Buddhachinaraj Hospital.

During the past decade, Buddhachinaraj Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Buddhachinaraj Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Bioven Europe" with 1 trials sponsored, "Institut de Recherche pour le Developpement" with 1 trials sponsored, "Odonate Therapeutics, Inc." with 1 trials sponsored and "The HIV Netherlands Australia Thailand Research Collaboration" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buddhachinaraj Hospital" #1 collaborator was "Bhumibol Adulyadej Hospital" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Buddhachinnaraj Hospital" with 1 trials as a collaborator, "Chiang Rai Prachanukroh Hospital" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Buddhachinaraj Hospital" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "HIV Infections" (1 trials), "HIV-infected Participants With Latent TB Infection in High TB Burden Country" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Buddhachinaraj Hospital" in a lesser frequency.

Most popular intervention types in "Buddhachinaraj Hospital" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "5-Fluorouracil" (2 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Buddhachinaraj Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Buddhachinaraj Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Buddhachinaraj Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Buddhachinaraj Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".